Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.912 |
High Similarity |
NPD3027 |
Phase 3 |
0.876 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.876 |
High Similarity |
NPD1613 |
Approved |
0.8644 |
High Similarity |
NPD228 |
Approved |
0.85 |
High Similarity |
NPD5283 |
Phase 1 |
0.845 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.839 |
Intermediate Similarity |
NPD2684 |
Approved |
0.8372 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8346 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8264 |
Intermediate Similarity |
NPD7843 |
Approved |
0.8211 |
Intermediate Similarity |
NPD7157 |
Approved |
0.8195 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.8151 |
Intermediate Similarity |
NPD290 |
Approved |
0.8116 |
Intermediate Similarity |
NPD3060 |
Approved |
0.8095 |
Intermediate Similarity |
NPD1357 |
Approved |
0.8092 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8062 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8062 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.806 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.806 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.806 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8034 |
Intermediate Similarity |
NPD291 |
Approved |
0.803 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8017 |
Intermediate Similarity |
NPD3022 |
Approved |
0.8017 |
Intermediate Similarity |
NPD3021 |
Approved |
0.8016 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8015 |
Intermediate Similarity |
NPD4536 |
Approved |
0.8015 |
Intermediate Similarity |
NPD4538 |
Approved |
0.8015 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7984 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7955 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7917 |
Intermediate Similarity |
NPD968 |
Approved |
0.791 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7907 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7907 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7895 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7891 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7891 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7879 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7857 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7857 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7842 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7826 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7823 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7737 |
Intermediate Similarity |
NPD5735 |
Approved |
0.773 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7721 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7721 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.771 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.771 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7708 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7704 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7676 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7676 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7676 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7671 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7667 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7652 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7652 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7652 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7651 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7609 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7591 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7591 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7589 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7589 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7574 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7569 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7568 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7568 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7554 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7554 |
Intermediate Similarity |
NPD3054 |
Approved |
0.7554 |
Intermediate Similarity |
NPD3052 |
Approved |
0.7551 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7551 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7548 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.754 |
Intermediate Similarity |
NPD5535 |
Approved |
0.754 |
Intermediate Similarity |
NPD821 |
Approved |
0.7536 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7533 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7521 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7521 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7519 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7518 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7518 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7482 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7466 |
Intermediate Similarity |
NPD3536 |
Discontinued |
0.7465 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7458 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7458 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7445 |
Intermediate Similarity |
NPD3179 |
Approved |
0.7445 |
Intermediate Similarity |
NPD3180 |
Approved |
0.744 |
Intermediate Similarity |
NPD556 |
Approved |
0.7434 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7426 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7424 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7417 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7417 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7417 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7415 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7415 |
Intermediate Similarity |
NPD52 |
Approved |
0.741 |
Intermediate Similarity |
NPD4140 |
Approved |
0.741 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7397 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7397 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7391 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7388 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7388 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7379 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7379 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7373 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7368 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7368 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7358 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7355 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7351 |
Intermediate Similarity |
NPD37 |
Approved |
0.7343 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7343 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7328 |
Intermediate Similarity |
NPD1182 |
Approved |
0.7328 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD2154 |
Approved |
0.7324 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD2156 |
Approved |
0.7324 |
Intermediate Similarity |
NPD2155 |
Approved |
0.732 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD4966 |
Approved |
0.732 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7313 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7308 |
Intermediate Similarity |
NPD3596 |
Phase 2 |
0.7302 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7297 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7153 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7286 |
Intermediate Similarity |
NPD3059 |
Approved |
0.7286 |
Intermediate Similarity |
NPD3062 |
Approved |
0.728 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1819 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1818 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1817 |
Approved |
0.7279 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD1820 |
Approved |
0.7279 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7266 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD3056 |
Clinical (unspecified phase) |
0.7265 |
Intermediate Similarity |
NPD9365 |
Approved |
0.7241 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7239 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7234 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7226 |
Intermediate Similarity |
NPD558 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD3691 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD3690 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7218 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7218 |
Intermediate Similarity |
NPD9381 |
Approved |
0.7218
|
Intermediate Similarity |
NPD9384 |
Approved |